Regeneron Pharmaceuticals, Inc. REGN
920.69 USD -1.71 (-0.19%)
Regular-session close
920.69 0.00 0.00%
After hours · Nov 20, 6:14 PM ET
916.66 Day range 948.42
600.66 52-week range 973.36
- YTD
- +19.28%
- 1 year
- +24.92%
REGN revenue history
Revenue is income from the company’s ordinary business activities.
14,342,900,000 USD
FY 2025 · Period ended
Coverage: complete. Values in USD; not inflation adjusted.
Reporting currency is USD by the source’s USD conversion factor of 1; the source does not name the currency.
Scroll the table to see all values →
| Fiscal period | Period end | Revenue | YoY change | YoY % |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | 14,342,900,000 | 140,900,000 | 0.99% |
| FY 2024 | 2024-12-31 | 14,202,000,000 | 1,084,800,000 | 8.27% |
| FY 2023 | 2023-12-31 | 13,117,200,000 | 944,300,000 | 7.76% |
| FY 2022 | 2022-12-31 | 12,172,900,000 | -3,898,800,000 | -24.26% |
| FY 2021 | 2021-12-31 | 16,071,700,000 | 7,574,600,000 | 89.14% |
| FY 2020 | 2020-12-31 | 8,497,100,000 | 1,939,500,000 | 29.58% |
| FY 2019 | 2019-12-31 | 6,557,600,000 | 1,412,000,000 | 27.44% |
| FY 2018 | 2018-12-31 | 5,145,600,000 | -726,600,000 | -12.37% |
| FY 2017 | 2017-12-31 | 5,872,200,000 | 1,011,800,000 | 20.82% |
| FY 2016 | 2016-12-31 | 4,860,400,000 | 756,672,000 | 18.44% |
| FY 2015 | 2015-12-31 | 4,103,728,000 | 1,284,171,000 | 45.55% |
| FY 2014 | 2014-12-31 | 2,819,557,000 | 714,812,000 | 33.96% |
| FY 2013 | 2013-12-31 | 2,104,745,000 | 726,268,000 | 52.69% |
| FY 2012 | 2012-12-31 | 1,378,477,000 | 932,653,000 | 209.20% |
| FY 2011 | 2011-12-31 | 445,824,000 | -13,250,000 | -2.89% |
| FY 2010 | 2010-12-31 | 459,074,000 | 79,806,000 | 21.04% |
| FY 2009 | 2009-12-31 | 379,268,000 | 140,811,000 | 59.05% |
| FY 2008 | 2008-12-31 | 238,457,000 | 113,433,000 | 90.73% |
| FY 2007 | 2007-12-31 | 125,024,000 | 61,577,000 | 97.05% |
| FY 2006 | 2006-12-31 | 63,447,000 | -2,746,000 | -4.15% |
| FY 2005 | 2005-12-31 | 66,193,000 | -107,824,000 | -61.96% |
| FY 2004 | 2004-12-31 | 174,017,000 | 116,520,000 | 202.65% |
| FY 2003 | 2003-12-31 | 57,497,000 | 35,509,000 | 161.49% |
| FY 2002 | 2002-12-31 | 21,988,000 | 15,000 | 0.07% |
| FY 2001 | 2001-12-31 | 21,973,000 | -37,303,000 | -62.93% |
| FY 2000 | 2000-12-31 | 59,276,000 | 24,777,000 | 71.82% |
| FY 1999 | 1999-12-31 | 34,499,000 | -3,828,000 | -9.99% |
| FY 1998 | 1998-12-31 | 38,327,000 | 5,227,000 | 15.79% |
| FY 1997 | 1997-12-31 | 33,100,000 | 8,986,000 | 37.26% |
| FY 1996 | 1996-12-31 | 24,114,000 | -3,270,503 | -11.94% |
| FY 1995 | 1995-12-31 | 27,384,503 | 4,192,746 | 18.08% |
| FY 1994 | 1994-12-31 | 23,191,757 | Not available | Not available |
Percentage growth is shown only when the same fiscal period one year earlier has a positive value. Missing periods are not estimated.
Company-reported financial statements. Retrieved 2026-07-31T06:02:23.000Z. Retrieval time is not a report date.
Open full statementsUse Add to watchlist above to save this stock.
